Regulatory Issues and Challenges Associated with the Development of Performance Specifications for Modified Release Parenteral Products
- 13 September 2011
- book chapter
- Published by Springer Science and Business Media LLC
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Online Monitoring of PLGA Microparticles Formation Using Lasentec Focused Beam Reflectance (FBRM) and Particle Video Microscope (PVM)The AAPS Journal, 2010
- Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugsAdvanced Drug Delivery Reviews, 2010
- Quality‐by‐Design (QbD): An Integrated Process Analytical Technology (PAT) Approach for Real‐Time Monitoring and Mapping the State of a Pharmaceutical Coprecipitation ProcessJournal of Pharmaceutical Sciences, 2010
- Non-invasive in vivo evaluation of in situ forming PLGA implants by benchtop magnetic resonance imaging (BT-MRI) and EPR spectroscopyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug DeliveryMolecular Pharmaceutics, 2009
- Role of Particle Size in Phagocytosis of Polymeric MicrospheresPharmaceutical Research, 2008
- Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulinBiomaterials, 2007
- Liposome OpsonizationJournal of Liposome Research, 2005
- Systemic Availability and Lymphatic Transport of Human Growth Hormone Administered by Subcutaneous InjectionJournal of Pharmaceutical Sciences, 2000
- Studies on the absorption of practically water-insoluble drugs following injection. II. Intramuscular absorption from aqueous suspensions in rats.CHEMICAL & PHARMACEUTICAL BULLETIN, 1981